The YGR182C antibody is a polyclonal antibody targeting the putative protein encoded by the YGR182C gene in Saccharomyces cerevisiae (Baker’s yeast). Despite its classification as a "dubious" open reading frame (ORF) with no confirmed functional protein product , this antibody has been utilized in research to investigate potential roles in chromatin organization and gene regulation . The antibody is commercially available through providers such as Cusabio and THE BioTek, with applications in Western Blot (WB) and Chromatin Immunoprecipitation (ChIP) .
The YGR182C gene is annotated as a non-essential, dubious ORF in the S. cerevisiae genome, with no conserved domains or experimental evidence supporting protein expression . Key features include:
| Attribute | Details |
|---|---|
| UniProt ID | P53300 |
| Gene Locus | Chromosome VII (YGR182C) |
| Predicted Molecular Weight | ~25 kDa (theoretical) |
| Sequence Length | 215 amino acids |
Despite its dubious status, the YGR182C antibody has been employed in studies analyzing chromatin interactions, such as Htz1 (histone variant H2A.Z) association with promoters .
The YGR182C antibody has been used in ChIP assays to study histone H2A.Z (Htz1) localization at promoters of genes like GAL1 and ribosomal protein genes (RPL13A, RPS16B) . For example:
ChIP Results: Htz1 association with the GAL1 promoter was quantified using this antibody, revealing ~2% input DNA binding under specific conditions .
The antibody’s utility highlights the importance of exploring uncharacterized genomic regions. While YGR182C is annotated as non-functional, its antibody’s cross-reactivity in chromatin studies suggests potential regulatory roles or technical artifacts requiring stringent validation .
YGR182C is a systematic gene identifier in the yeast Saccharomyces cerevisiae genome database. This designation follows the standard yeast nomenclature where "Y" indicates yeast origin, "G" refers to the specific chromosome (in this case chromosome VII), "R" indicates right arm of the chromosome, and "182" denotes the specific open reading frame, with "C" indicating the Watson strand. The protein encoded by this gene has significance in fundamental cellular processes, making antibodies against this protein valuable tools for investigating protein-protein interactions, cellular localization, and functional studies in yeast models. Specific antibodies developed against this protein enable researchers to track its expression, localization, and modifications under various experimental conditions, providing insights into basic cellular mechanisms .
Proper antibody validation is essential to ensure experimental reproducibility and reliability. For YGR182C antibodies, researchers should implement a multi-step validation process:
Specificity testing: Perform Western blot analysis comparing wild-type samples with YGR182C knockout/deletion strains to confirm antibody specificity.
Cross-reactivity assessment: Test against related proteins, particularly if studying conserved protein families.
Application-specific validation: Validate the antibody separately for each intended application (Western blot, immunoprecipitation, immunofluorescence) as performance may vary significantly between applications.
Reproducibility testing: Confirm consistent results across multiple biological replicates and antibody lots.
Positive and negative controls: Include appropriate controls in every experiment to validate antibody performance.
This comprehensive validation approach reduces experimental variability and enhances research reproducibility, addressing one of the most common challenges in antibody-based research .
Maintaining antibody stability is crucial for experimental reproducibility and reliability. YGR182C antibodies, like most research antibodies, require specific storage and handling conditions:
Storage temperature: Store antibody aliquots at -20°C for long-term storage. For antibodies in regular use, small working aliquots can be kept at 4°C for up to two weeks to minimize freeze-thaw cycles.
Aliquoting strategy: Upon receiving a new antibody, immediately prepare multiple small-volume aliquots (10-50 μL) to minimize freeze-thaw cycles, which cause protein denaturation and reduced activity.
Buffer considerations: Most antibodies are stable in buffers containing:
Phosphate buffered saline (PBS)
Small amounts of carrier protein (0.1-1% BSA)
Preservative (0.02-0.05% sodium azide or thimerosal)
Avoid: Repeated freeze-thaw cycles, exposure to light (especially for fluorophore-conjugated antibodies), and contamination.
Reconstitution documentation: Maintain detailed records of reconstitution date, buffer composition, and aliquot storage locations.
Following these guidelines helps ensure consistent antibody performance across experiments and extends the functional lifespan of valuable research reagents .
Implementing proper experimental controls is essential when working with YGR182C antibodies to ensure valid and interpretable results:
Known samples expressing YGR182C protein
Recombinant YGR182C protein (when available)
Wild-type yeast strains with documented YGR182C expression
YGR182C knockout/deletion strains
Secondary antibody-only controls (to assess non-specific binding)
Isotype controls (antibodies of the same isotype but with irrelevant specificity)
Pre-immune serum controls (for polyclonal antibodies)
Loading controls (housekeeping proteins) for Western blots
Input sample controls for immunoprecipitation experiments
Blocking peptide controls to confirm antibody specificity
Antibody dilution series to establish optimal working concentration
Multiple antibodies targeting different epitopes of YGR182C (when available)
Cryo-electron microscopy has emerged as a powerful tool for characterizing antibody-antigen interactions at near-atomic resolution. For YGR182C antibody characterization, cryo-EM offers several distinct advantages:
Epitope mapping: Cryo-EM can visualize the precise binding interface between YGR182C protein and its antibodies, revealing conformational epitopes that may not be detectable through traditional epitope mapping techniques. This structural information can guide the development of more specific antibodies with improved target recognition.
Polyclonal antibody analysis: As demonstrated in recent research, cryo-EM combined with computational methods allows for the identification of polyclonal antibody families directly from structural data. This approach can be applied to analyze YGR182C-specific antibody responses:
Form immune complexes by incubating YGR182C protein with polyclonal antibodies
Perform cryo-EM imaging of these complexes
Analyze the resulting density maps to identify distinct antibody binding patterns
Match these patterns with next-generation sequencing data from B-cells
Structural validation: Cryo-EM provides direct visualization of antibody binding, confirming specificity in a way that complements traditional biochemical validation methods.
Workflow integration: The identified sequences can be used to produce monoclonal antibodies that bind to the exact epitopes visualized in the cryo-EM maps, as verified through follow-up binding assays:
Biolayer interferometry (BLI)
Sandwich ELISA
Structural confirmation through cryo-EM of the resulting complexes
This integrative approach can significantly reduce the time required for antibody characterization from months to weeks, enabling more rapid development of specific antibodies against YGR182C protein .
Recent advances in computational biology and machine learning offer promising approaches to enhance antibody specificity and affinity without extensive wet-lab experimentation. For YGR182C antibodies, these methods provide powerful tools for antibody optimization:
Protein language models for in silico evolution:
Stanford researchers have developed machine learning models that can predict improved antibody variants from a single antibody sequence. This approach enables:
Exploration of a mutational space orders of magnitude larger than possible with traditional in vivo evolutionary methods
Prediction of a small, manageable set (~10) of high-likelihood protein variants with potentially enhanced properties
Rapid computational screening (seconds versus weeks for traditional methods)
Input the sequence of an existing YGR182C antibody into the protein language model
Generate predictions for variants with potentially improved binding characteristics
Synthesize the top candidate sequences
Validate improvements through binding assays:
Biolayer interferometry to measure binding kinetics
Thermostability assays to assess structural robustness
Specificity testing against related proteins
Dramatically reduced experimental burden
Ability to identify non-intuitive mutations that improve antibody performance
Exploration of sequence space beyond what random mutagenesis typically covers
Prediction of variants with multiple beneficial properties (e.g., improved affinity and thermostability)
This computational approach represents a paradigm shift in antibody engineering, potentially reducing development time and resources while yielding antibodies with superior research applications .
Advanced imaging technologies combined with specific antibodies offer powerful approaches for studying YGR182C protein localization in complex cellular contexts:
Sequential immunofluorescence: Apply and remove YGR182C antibodies sequentially along with other organelle markers to build comprehensive localization maps. This approach requires antibody stripping protocols that preserve sample integrity.
Spectral unmixing: Use fluorophores with distinct but overlapping spectra, then apply computational algorithms to separate signals based on their spectral signatures, allowing simultaneous visualization of YGR182C with multiple cellular markers.
Mass cytometry imaging: Conjugate YGR182C antibodies with isotopically pure metals rather than fluorophores, allowing detection by mass spectrometry with minimal signal overlap. This technique permits simultaneous imaging of dozens of proteins.
| Parameter | Recommended Approach | Rationale |
|---|---|---|
| Fixation method | Paraformaldehyde (4%) followed by controlled permeabilization | Preserves subcellular structures while allowing antibody access |
| Antibody concentration | Titration series (typically 1-10 μg/mL) | Determines optimal signal-to-noise ratio |
| Blocking agent | 5% BSA or serum from secondary antibody host species | Reduces non-specific binding |
| Incubation time | 1-2 hours at room temperature or overnight at 4°C | Ensures complete epitope binding |
| Washing stringency | Multiple PBS-T washes (3-5x, 5 minutes each) | Removes unbound antibodies |
Co-localization with known YGR182C interaction partners
Comparison with GFP-tagged YGR182C protein expression
Z-stack analysis to distinguish true co-localization from superimposition
By optimizing these parameters, researchers can achieve high-resolution mapping of YGR182C protein localization in relation to other cellular components, providing insights into its functional interactions and regulatory mechanisms .
When different antibody clones targeting YGR182C produce contradictory results, a systematic troubleshooting approach is necessary to resolve these discrepancies:
Map the binding epitopes of each antibody clone using techniques such as:
Peptide arrays
Hydrogen-deuterium exchange mass spectrometry
Cryo-EM structural analysis
Determine if the antibodies recognize different conformational states or post-translational modifications of YGR182C
Confirm protein presence and identity using mass spectrometry
Validate localization using GFP-tagged YGR182C constructs
Verify functional data with genetic approaches (knockouts, CRISPR editing)
| Validation Level | Techniques | Strength of Evidence |
|---|---|---|
| Basic | Western blot with controls | Moderate |
| Intermediate | Multiple antibodies to different epitopes | Strong |
| Advanced | Genetic knockouts + antibody testing | Very strong |
| Gold standard | Multiple methods + structure-based validation | Definitive |
For contradictory localization: Verify fixation compatibility, permeabilization methods, and epitope accessibility
For contradictory interaction partners: Use stringent IP conditions and reciprocal co-IP approaches
For contradictory expression levels: Normalize to multiple housekeeping genes and validate with absolute quantification
Document all antibody details (vendor, catalog number, lot, dilution)
Report all validation steps performed
Consider contradictory results as potentially revealing post-translational modifications or alternative conformations of YGR182C
This systematic approach not only resolves contradictions but may also uncover previously unknown biological properties of YGR182C protein .
Successful immunoprecipitation (IP) of YGR182C requires careful optimization of experimental conditions to maintain protein conformation and preserve protein-protein interactions:
| Buffer Component | Recommended Range | Purpose |
|---|---|---|
| Base buffer | HEPES or Tris (pH 7.4-8.0) | Maintains physiological pH |
| Salt concentration | 100-150 mM NaCl (standard) or 50-75 mM (for weak interactions) | Balances specificity and preservation of interactions |
| Detergent | 0.1-1% NP-40 or Triton X-100 (membrane proteins) | Solubilizes proteins while preserving interactions |
| Protease inhibitors | Complete cocktail (fresh) | Prevents degradation during extraction |
| Phosphatase inhibitors | Sodium orthovanadate, sodium fluoride, β-glycerophosphate | Preserves phosphorylation states |
| Reducing agents | 1-5 mM DTT or β-mercaptoethanol | Maintains protein structure |
Direct coupling: Covalently link antibodies to beads (using commercially available kits) to eliminate antibody contamination in the eluate
Pre-clearing: Incubate lysate with beads alone before adding antibody to reduce non-specific binding
Sequential IP: For confirming protein complexes, perform tandem IP targeting different components
Harvest cells in mid-log phase for yeast studies
Prepare lysate using gentle lysis conditions (avoid harsh sonication)
Pre-clear lysate with protein A/G beads (1 hour, 4°C)
Incubate cleared lysate with YGR182C antibody (2-4 μg per mg of protein) overnight at 4°C
Add protein A/G beads and rotate for 2-4 hours at 4°C
Wash 4-5 times with decreasing salt concentration
Elute using gentle conditions (glycine pH 2.8 or competing peptide)
Input control (5-10% of starting material)
IgG control (same species and concentration as test antibody)
Blocking peptide competition
Reverse IP (using antibodies against known interaction partners)
This optimized protocol maximizes the chances of successful YGR182C immunoprecipitation while maintaining physiologically relevant protein interactions .
Designing epitope-specific antibodies for distinguishing YGR182C protein isoforms requires strategic planning and implementation of several key approaches:
Bioinformatic analysis:
Identify unique sequence regions in each isoform using multiple sequence alignment
Predict surface accessibility using structural modeling tools
Assess hydrophilicity, antigenicity, and secondary structure
Critical regions to target:
Splice junction-spanning epitopes for splice variants
Post-translational modification sites
Conformational epitopes unique to specific isoforms
Cross-reactivity testing:
Test against all known YGR182C isoforms
Include closely related proteins as controls
Specificity confirmation:
Isoform-specific knockdown/knockout validation
Mass spectrometry confirmation of immunoprecipitated proteins
Epitope mapping using peptide arrays or hydrogen-deuterium exchange
Application-specific validation:
Validate separately for Western blot, immunoprecipitation, and immunofluorescence
Confirm specificity in the cellular context of interest
By following this strategic approach, researchers can develop antibodies capable of distinguishing specific YGR182C isoforms, enabling more precise studies of isoform-specific functions in different cellular contexts .
Accurate protein quantification is essential for understanding YGR182C expression levels and regulatory changes. Several antibody-based methods offer different advantages depending on the research question:
Optimization parameters:
Use gradient gels to ensure optimal protein separation
Implement wet transfer for consistent protein transfer
Apply fluorescent secondary antibodies for wider linear dynamic range
Include standard curves using recombinant YGR182C protein
Normalization strategy:
Use multiple housekeeping proteins appropriate for the experimental condition
Apply total protein normalization methods (e.g., stain-free technology, REVERT total protein stain)
Validate housekeeping protein stability under experimental conditions
| ELISA Format | Sensitivity Range | Advantages | Limitations |
|---|---|---|---|
| Direct ELISA | 10-100 ng/mL | Simple protocol | Lower sensitivity |
| Sandwich ELISA | 0.1-10 ng/mL | Higher specificity and sensitivity | Requires two non-competing antibodies |
| Competitive ELISA | 0.01-1 ng/mL | Works with small proteins and peptides | More complex optimization |
Single-molecule counting: Technologies like Singulex Erenna or Quanterix Simoa offer femtomolar sensitivity
Digital ELISA: Provides absolute quantification with expanded dynamic range
Mass spectrometry with antibody enrichment: Combines specificity of antibodies with the precision of MS
Include recombinant YGR182C protein standards in every assay
Use internal reference samples across experiments
Participate in inter-laboratory standardization when possible
Document detailed assay conditions (antibody concentrations, incubation times, wash protocols)
Report linear dynamic range of the assay
Provide coefficient of variation for technical and biological replicates
By selecting and optimizing the appropriate quantification method based on the expected abundance and sample type, researchers can achieve reliable and reproducible quantification of YGR182C protein levels .